Clinical Trial Update: A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

The Phase 2 study evaluating RTA 402 (bardoxolone methyl) for measuring glomerular filtration rate in chronic kidney disease patients with type 2 diabetes has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• RTA 402 (bardoxolone methyl)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Chronic Kidney Disease, Type 2 Diabetes | Phase 2 | Status: TERMINATED